Diana Wojcik
Mercer Island, WA (USA)
Role(s):
Other
Adesso Diagnostics
Find More Startups
Startup
Location:
Seattle
Industry:
Bio-Technology
Year Founded:
2011
Number Employees:
1-10 people
Business Stage:
Growth (not profitable)
Entity Type:
Limited Liability Partnership
Description:
We see our diagnostic device in the hands of every medical professional in the US and abroad. Our point-of-care diagnostic device has the capacity to detect any infectious disease for which there exists an identifiable DNA sequence, allowing us to bring diagnostic medicine directly into the hands of doctors, from the lab to the bedside. Utilizing the world’s most sensitive nanosensor, our device yields a quicker and more accurate diagnosis than any competitor. Adesso has the exclusive lifetime rights to the patents for this technology, taking the edge away from future competitors. Our device would also be versatile as well as inexpensive, making it accessible to a wide market base. The microfluidic “lab-on-a-chip” works by translating chemical and biochemical information into an electrical signal that can be powered by any CMOS power source (i.e. a mobile phone or laptop), thereby easily accessible to the developed and developing world alike.